Tracking and clarifying differential traits of classical- and atypical L-type bovine spongiform encephalopathy prions after transmission from cattle to cynomolgus monkeys.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
01
2019
accepted:
29
04
2019
entrez:
17
5
2019
pubmed:
17
5
2019
medline:
22
1
2020
Statut:
epublish
Résumé
Classical- (C-) and atypical L-type bovine spongiform encephalopathy (BSE) prions cause different pathological phenotypes in cattle brains, and the disease-associated forms of each prion protein (PrPSc) has a dissimilar biochemical signature. Bovine C-BSE prions are the causative agent of variant Creutzfeldt-Jakob disease. To date, human infection with L-BSE prions has not been reported, but they can be transmitted experimentally from cows to cynomolgus monkeys (Macaca fascicularis), a non-human primate model. When transmitted to monkeys, C- and L-BSE prions induce different pathological phenotypes in the brain. However, when isolated from infected brains, the two prion proteins (PrPSc) have similar biochemical signatures (i.e., electrophoretic mobility, glycoforms, and resistance to proteinase K). Such similarities suggest the possibility that L-BSE prions alter their virulence to that of C-BSE prions during propagation in monkeys. To clarify this possibility, we conducted bioassays using inbred mice. C-BSE prions with or without propagation in monkeys were pathogenic to mice, and exhibited comparable incubation periods in secondary passage in mice. By contrast, L-BSE prions, either with or without propagation in monkeys, did not cause the disease in mice, indicating that the pathogenicity of L-BSE prions does not converge towards a C-BSE prion type in this primate model. These results suggest that, although C- and L-BSE prions propagated in cynomolgus monkeys exhibit similar biochemical PrPSc signatures and consist of the monkey amino acid sequence, the two prions maintain strain-specific conformations of PrPSc in which they encipher and retain unique pathogenic traits.
Identifiants
pubmed: 31095605
doi: 10.1371/journal.pone.0216807
pii: PONE-D-19-02122
pmc: PMC6522098
doi:
Substances chimiques
Prions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216807Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2011 Jan 14;6(1):e15839
pubmed: 21264286
Jpn J Infect Dis. 2011;64(1):81-4
pubmed: 21266763
Emerg Infect Dis. 2011 Sep;17(9):1636-44
pubmed: 21888788
J Neurovirol. 1999 Jun;5(3):300-7
pubmed: 10414520
Nature. 1996 Jun 27;381(6585):743-4
pubmed: 8657276
J Infect Dis. 2007 Apr 1;195(7):989-96
pubmed: 17330789
J Clin Microbiol. 2007 Jun;45(6):1821-9
pubmed: 17442800
Prion. 2011 Apr-Jun;5(2):103-8
pubmed: 21597334
Cell. 1987 Nov 20;51(4):651-62
pubmed: 2890436
Microbiol Immunol. 2009 Dec;53(12):704-7
pubmed: 19954458
J Mol Biol. 2006 Jul 21;360(4):907-20
pubmed: 16782127
PLoS One. 2008 Aug 20;3(8):e3017
pubmed: 18714385
J Virol Methods. 2010 May;165(2):261-7
pubmed: 20152861
J Virol. 2008 Apr;82(7):3697-701
pubmed: 18234793
PLoS Pathog. 2012;8(3):e1002582
pubmed: 22479179
Vet Res. 2015 Jul 13;46:81
pubmed: 26169916
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Biochem Biophys Res Commun. 1999 Nov 30;265(3):652-7
pubmed: 10600476
J Gen Virol. 2004 Aug;85(Pt 8):2471-2478
pubmed: 15269389
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3065-70
pubmed: 14970340
Virology. 1998 Nov 25;251(2):297-301
pubmed: 9837794
J Virol. 2007 Jan;81(2):835-43
pubmed: 17079295
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16990-5
pubmed: 19805070
EMBO Rep. 2004 Jan;5(1):110-5
pubmed: 14710195
PLoS Pathog. 2007 Mar;3(3):e31
pubmed: 17352534
EMBO J. 2002 Dec 2;21(23):6358-66
pubmed: 12456643
Microbiol Immunol. 1985;29(6):543-51
pubmed: 3930925
J Virol. 2016 Nov 14;90(23):10867-10874
pubmed: 27681129
J Gen Virol. 1987 Jul;68 ( Pt 7):1875-81
pubmed: 3110370
Vet Res. 2016 Nov 8;47(1):112
pubmed: 27825366
J Neuropathol Exp Neurol. 2013 Mar;72(3):211-8
pubmed: 23399901
Vet J. 2008 Oct;178(1):126-9
pubmed: 17692544
J Gen Virol. 2013 Dec;94(Pt 12):2819-2827
pubmed: 24045112
Virology. 2004 Mar 1;320(1):40-51
pubmed: 15003861
J Neurosci. 2007 Jun 27;27(26):6965-71
pubmed: 17596445
Science. 1997 Jan 17;275(5298):402-5
pubmed: 8994041
Neuron. 2002 Jun 13;34(6):921-32
pubmed: 12086640
Nature. 1997 Oct 2;389(6650):498-501
pubmed: 9333239
J Gen Virol. 2009 Jan;90(Pt 1):261-8
pubmed: 19088297
Biochemistry. 2006 Dec 26;45(51):15573-82
pubmed: 17176078
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4142-7
pubmed: 11259641
PLoS One. 2017 Feb 23;12(2):e0172428
pubmed: 28231300
Jpn J Infect Dis. 2007 Sep;60(5):305-8
pubmed: 17881874
Cell. 1985 Apr;40(4):735-46
pubmed: 2859120
Emerg Infect Dis. 2012 Jan;18(1):142-5
pubmed: 22261009
Jpn J Infect Dis. 2011;64(1):50-4
pubmed: 21266755
J Natl Cancer Inst. 1968 Jul;41(1):125-43
pubmed: 4873849
Jpn J Infect Dis. 2006 Apr;59(2):100-7
pubmed: 16632909
Nature. 1996 Oct 24;383(6602):685-90
pubmed: 8878476
Pathogens. 2013 Jul 30;2(3):520-32
pubmed: 25437205
Br Med Bull. 2003;66:255-65
pubmed: 14522863
Viruses. 2014 Oct 02;6(10):3766-77
pubmed: 25279820
Int J Exp Pathol. 2013 Oct;94(5):320-8
pubmed: 24020404
Emerg Infect Dis. 2008 Dec;14(12):1898-901
pubmed: 19046515